TP53 and hepatocellular carcinoma: Since IDH1/H2 and TP53 mutations are found in a large percentage of HCC patients,31 we further analyzed the correlation between IDH1, IDH2, and p53 mutations and the expression of EPDR1 in HCC using TCGA database (Figure S4).